TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Dala Vård & Vaccin AB
Closing information (x1000 DKK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
9,090
|
8,282
|
5,372 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
705
|
1,380
|
211 |
EBITDA |
727
|
1,432
|
273 |
Total assets |
1,950
|
2,257
|
1,119 |
Current assets |
1,733
|
2,008
|
787 |
Current liabilities |
949
|
1,010
|
816 |
Equity capital |
892
|
1,174
|
302 |
- share capital |
38
|
39
|
43 |
Employees (average) |
5
![]() |
5
|
4 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
45.7%
|
52.0%
|
27.0% |
Turnover per employee |
1,818
|
1,656
|
1,343 |
Profit as a percentage of turnover |
7.8%
|
16.7%
|
3.9% |
Return on assets (ROA) |
36.2%
|
61.1%
|
18.9% |
Current ratio |
182.6%
|
198.8%
|
96.4% |
Return on equity (ROE) |
79.0%
|
117.5%
|
69.9% |
Change turnover |
1,105
|
3,382
|
317 |
Change turnover % |
14%
|
69%
|
6% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
25%
|
33% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.